Advancing Precision Medicine through Nanotechnology-Enabled Drug Delivery Systems
DOI:
https://doi.org/10.63995/IICE3293Keywords:
Artificial Intelligence, Biomimetic Nanocarriers, Drug Delivery Systems, Lipid Nanoparticles, Precision Medicine, Theranostic NanoplatformsAbstract
Nanotechnology has emerged as a transformative force in modern medicine, revolutionizing how therapeutic agents are designed, delivered, and monitored within the human body. By engineering nanoparticles at the molecular scale, researchers have developed smart drug delivery systems capable of crossing complex biological barriers and achieving targeted, controlled release of therapeutics. Lipid-based nanocarriers, such as liposomes, solid lipid nanoparticles, and lipid nanoparticles (LNPs), have redefined treatment efficiency—most notably demonstrated through the success of mRNA vaccine technologies. Similarly, polymeric, dendrimer, and albumin-based nanosystems provide biocompatible platforms for sustained and site-specific delivery of complex drugs. Inorganic nanomaterials, including gold, magnetic, and silica nanoparticles, add new dimensions through stimuli-responsive and multifunctional capabilities. Recent breakthroughs in crossing the blood–brain barrier, integrating theranostic platforms, and applying artificial intelligence for nanocarrier design further expand the scope of precision medicine. Despite challenges in large-scale production, biocompatibility, and regulatory standardization, nanotechnology continues to reshape therapeutic strategies, offering unprecedented opportunities for personalized, efficient, and minimally invasive healthcare solutions.
Downloads
References
[1] Sweety Verma. “Nanotechnology in Drug Delivery: Precision Medicine of the Future”. In: GIJ 2.02 (2022), pp. 1–12.
[2] Tao L Lowe, Vivek Agrahari, Rangaramanujam M Kannan, and Sujatha Kannan. “Nanotechnology enabled regenerative medicine for neurological disorders”. In: Advanced drug delivery reviews 148 (2019), p. 1.
[3] Shiza Malik, Khalid Muhammad, and Yasir Waheed. “Emerging applications of nanotechnology in healthcare and medicine”. In: Molecules 28.18 (2023), p. 6624.
[4] Rajip Nepal, Jyoti Phogat, Dipendra Kohar, and Dev Kumar Ray. “Nanotechnology-Enabled Precision Drug Delivery: Revolutionizing Therapeutic Strategies for Health and Disease”. In: Journal of Pharma Insights and Research 1.1 (2023), pp. 30–35.
[5] Inge K Herrmann and Matthias Rösslein. Personalized medicine: the enabling role of nanotechnology. 2016.
[6] Marc Heylen, Patrick Bossuyt, Philippe Provoost, David Borremans, and Christine Rampelberg. “Making Antennas for 6G”. In: Fusion of Multidisciplinary Research, An International Journal (FMR) 3.1 (2022), pp. 235–247.
[7] Panneerselvam Theivendren, Selvaraj Kunjiappan, Parasuraman Pavadai, Kaveena Ravi, Anusuya Murugavel, Avinash Dayalan, and A Santhana Krishna Kumar. “Revolutionizing cancer immunotherapy: emerging nanotechnology-driven drug delivery systems for enhanced therapeutic efficacy”. In: ACS Measurement Science Au 5.1 (2024), pp. 31–55.
[8] Ioannis S Vizirianakis. “Nanomedicine and personalized medicine toward the application of pharmacotyping in clinical practice to improve drug-delivery outcomes”. In: Nanomedicine: Nanotechnology, Biology and Medicine 7.1 (2011), pp. 11–17.
[9] Ms Shiny Ahmed, Priyam Jyoti Das, and Santa Mandal. “26 PHARMACY OF TOMORROW: NAVIGATING INNOVATIONS IN TECHNOLOGY, PERSONALIZED MEDICINE, AND NANOTECHNOLOGY”. In: INNOVATIVE RESEARCH (), p. 179.
[10] V Jyothi Krishna, L Swathi, and S Surya Lakshmi. “Integrating Immunotherapy and Nanotechnology in Advanced Drug Delivery Systems for Precision Cancer Therapy”. In: Journal of Clinical and Pharmaceutical Research (2024).
[11] Hamza Khalifa Ibrahim. “From nanotech to AI: the cutting-edge technologies shaping the future of medicine”. In: African Journal of Advanced Pure and Applied Sciences (AJAPAS) (2024), pp. 410–427.
[12] Randa Elqassas, Hazem AS Alrakhawi, Mohammed M Elsobeihi, Basel Habil, Bassem S AbuNasser, and Samy S Abu-Naser. “Convergence of Nanotechnology and Artificial Intelligence: Revolutionizing Healthcare and Beyond”. In: (2024).
[13] Md Faiyazuddin, Yogesh Chaudhari, Manisha Chaudhari, Amol D Gholap, Gowri Sundaram, Mohammad Intakhab Alam, and Thomas J Webster. “Navigating Nanotechnology Healthcare Horizons: A Comprehensive Review of IoT and SIoT Evolution for Patient-Centric Perspectives”. In: Journal of Biomedical Nanotechnology 20.12 (2024), pp. 1791–1803.
[14] Sarah Afiq, Maryam Fikri, Rahman Ethan, and Amsyar Isfahann. “Acknowledging the Role of Buck Converter in DC-DC Conversion”. In: Fusion of Multidisciplinary Research, An International Journal (FMR) 3.1 (2022), pp. 287–301.
[15] Haico te Kulve and Arie Rip. “Economic and societal dimensions of nanotechnology-enabled drug delivery”. In: Expert opinion on drug delivery 10.5 (2013), pp. 611–622.
[16] Sneha Thakur, Mandava Kiranmai, K Venu Madhav, and P Naga Haritha. “Smart Drug Delivery Systems—Integrating IoT and Nanotechnology for Enhanced Therapeutic Efficacy”. In: Recent Developments in Microbiology, Biotechnology and Pharmaceutical Sciences. CRC Press, 2024, pp. 828–833.
[17] Qiaoxia Zhou, Qiongliang Liu, Yan Wang, Jie Chen, Otmar Schmid, Markus Rehberg, and Lin Yang. “Bridging smart nanosystems with clinically relevant models and advanced imaging for precision drug delivery”. In: Advanced Science 11.14 (2024), p. 2308659.
[18] Shiyi Huang and Xianting Ding. “Precise design strategies of nanotechnologies for controlled drug delivery”. In: Journal of Functional Biomaterials 13.4 (2022), p. 188.
[19] Qinqin Hu, Hua Li, Lihua Wang, Hongzhou Gu, and Chunhai Fan. “DNA nanotechnologyenabled drug delivery systems”. In: Chemical reviews 119.10 (2018), pp. 6459–6506.
[20] Tereza Martin, Veronika Ondra, and Karolina Dominik. “The Role of Fiscal vs Monetary Policy in Modern Economics”. In: Fusion of Multidisciplinary Research, An International Journal (FMR) 3.2 (2022), pp. 329–341.
[21] Sayed Abdul Latif Maftunzada. “ADVANCEMENTS IN MEDICAL SENSORS ENABLED BY NANOTECHNOLOGY”. In: Academic research in educational sciences 5.7-8 (2024), pp. 49–58.
[22] Anirbandeep Bose and Tin Wui Wong. “Nanotechnology-enabled drug delivery for cancer therapy”. In: Nanotechnology applications for tissue engineering. Elsevier, 2015, pp. 173–193.
[23] K Arifa Siddiga and KP Nalini. “Fundamentals and Applications of Nanotechnology in Medicine”. In: ICFAN 2024 (2024).
[24] Aliu Olalekan Olatunji, Tariq Rafique, Hira Aslam, Naseem Akhter, Baneen C Gabble, Sri Pranita Cherukuri, Tufail Ahmad, and Asaad Babker. “Targeted Drug Delivery Systems In Nanomedicine: Enhancing Therapeutic Efficacy In Oncology And Beyond”. In: ().
[25] Arun Kumar Singh, Rishabha Malviya, Bhupendra Prajapati, Sudarshan Singh, Deepika Yadav, and Arvind Kumar. “Nanotechnology-aided advancement in combating the cancer metastasis”. In: Pharmaceuticals 16.6 (2023), p. 899.
[26] Lama Abujamous, Abderrezzaq Soltani, Hamda Al-Thawadi, and Abdelali Agouni. “Advances in nanotechnology-enabled drug delivery for combining PARP inhibitors and immunotherapy in advanced ovarian cancer”. In: Biomolecules and Biomedicine 24.2 (2024), p. 230.
[27] Venkat Ratnam Devadasu, Vivekanand Bhardwaj, and MNV Ravi Kumar. “Can controversial nanotechnology promise drug delivery?” In: Chemical reviews 113.3 (2013), pp. 1686–1735.
[28] Nima Mostafa, Arman Mohsen, Shahrad Mardin, and Ameen Elyas. “Deciphering the Mysteries: Seasonal Influenza and the Role of Flu Vaccines in Public Health”. In: Fusion of Multidisciplinary Research, An International Journal (FMR) 4.1 (2023), pp. 380–392.
[29] AKM Shafiul Kadir, Pranav Kumar Prabhakar, Mohammad Ullah Shemanto, Ashik Sharfaraz, Soumik Tripura, Ety Akhter, Rabeya Akter Urmi, Joye Kundu, and Tama Dutta. “A New Frontier in Drug Delivery Systems”. In: (2024).
[30] Mirza Salman Baig, Anas Ahmad, Rijawan Rajjak Pathan, and Rakesh Kumar Mishra. “Precision nanomedicine with bio-inspired nanosystems: recent trends and challenges in mesenchymal stem cells membrane-coated bioengineered nanocarriers in targeted nanotherapeutics”. In: Journal of Xenobiotics 14.3 (2024), pp. 827–872.
[31] Dharmesh Sisodiya, B Madhavilatha, Parijatha Bandigari, KM Katual, Niraj Gupta, Pavankumar Krosuri, Prabhakar Vishvakarma, and Shalini Singh Negi. “Bacterial Nanocarriers for Site-Specific Drug Delivery: Harnessing Microorganisms for Precision Medicine”. In: African Journal of Biological Sciences 6.9 (2024), pp. 2400–2420.
[32] Rui Xue Zhang, Jason Li, Tian Zhang, Mohammad A Amini, Chunsheng He, Brian Lu, Taksim Ahmed, HoYin Lip, Andrew M Rauth, and Xiao Yu Wu. “Importance of integrating nanotechnology with pharmacology and physiology for innovative drug delivery and therapy–an illustration with firsthand examples”. In: Acta Pharmacologica Sinica 39.5 (2018), pp. 825–844.
[33] Md Kazi Rokunuzzaman. “The Nanotech Revolution: Advancements in Materials and Medical Science”. In: Journal of Advancements in Material Engineering 9.2 (2024), pp. 1–10.
[34] Pollyanna Obi, Kingsley Eze, and Raphael Balogun. “Competition in Marketing: A Deep Dive into Advertising Rivalries”. In: Fusion of Multidisciplinary Research, An International Journal (FMR) 4.2 (2023), pp. 471–482.
[35] Binit Patel, Pravinkumar Darji, Praneeth Ivan Joel Fnu, Seshadri Nalla, Viratkumar Khatri, and Shalin Parikh. “A comprehensive review and insight into the latest advancements in nanotechnology”. In: Biosciences Biotechnology Research Asia 21.3 (2024), pp. 985–1000.
[36] Basanti Brar, Koushlesh Ranjan, Ankur Palria, Rajesh Kumar, Mayukh Ghosh, Sweety Sihag, and Prasad Minakshi. “Nanotechnology in colorectal cancer for precision diagnosis and therapy”. In: Frontiers in Nanotechnology 3 (2021), p. 699266.
[37] Svetlana Marković, Goran Popović, and Ljubomir Andjelković. “Mastering the Attention Economy: Strategies for Competing on Digital Platforms”. In: Fusion of Multidisciplinary Research, An International Journal (FMR) 5.1 (2024), pp. 568–578.
[38] Aparna Sharma, Deeksha Sharma, and Siddhartha Dan. “Nanotechnology-Enabled Biomaterials: Transforming Tuberculosis Management through Advanced Diagnosis, Targeted Drug Delivery, and Immunotherapy”. In: (2024).
[39] E Mohammadi, M Dastjerdi, A Jalali, S Akbari, and A Akbari. “Advancing Drug Delivery in Colorectal Cancer: A Comprehensive Exploration of Nanotechnology, Experimental Models, and Production Process Simulation”. In: (2024).
[40] Ioannis S Vizirianakis, Christina Karavasili, Elsa P Amanatiadou, and Dimitrios G Fatouros. “ADVANCING THE PRACTICAL CLINICAL UTILITY IN PERSONALIZED MEDICINE: CAPABILITIES AND LESSONS LEARNED FOR PHARMACOLOGY AND PHARMACEUTICS”. In: Nanotheranostics for Personalized Medicine. World Scientific, 2016, pp. 297–323.
[41] Taufik Mulla. “Chapter-3 Nanotechnology Applications in Drug Delivery”. In: Techniques and Innovative Research in Pharmaceutical Science (2024), p. 25.
[42] Meer Zeshanul Wazid. “Nanotechnology: revolutionizing drug delivery, diagnostics, and therapeutics”. In: (2024).
[43] Muner Mohammed Zakaria, Khaled Saud Mohammed Alzayed, Ahmed Ibrahim Meashi, Sultan Abdulrahman Al Ghamdi, Sultan Salih Salem Almowaled, Amal Abbas Alnakhly, Najat Ali Almalki, Maryam Mohammed Thani Suliman Ibrahim, Mohammed Hadi Hassan Alshahrani, Sulaiman Raja Alallasi, et al. “Revolutionizing Drug Delivery: Innovations And Challenges In Nanotechnology.” In: Journal of Namibian Studies 38 (2023).
[44] Muhammad Fahad Ali. “NANOTECHNOLOGY IN TARGETED CANCER THERAPY: ADVANCES IN DRUG DELIVERY SYSTEMS”. In: Journal of Health, Medical Research and Innovations 2.3 (2024), pp. 175–183.
[45] Saif Al-Deen H Hassan, Mohsin Najim Sarayyih Almaliki, Zahraa Abed Hussein, Hayder M Albehadili, Shaima Rabeea Banoon, Aswan Abboodi, and Moumal Al-Saady. “Development of nanotechnology by artificial intelligence: a comprehensive review”. In: Journal of Nanostructures 13.4 (2023), pp. 915–932.
[46] Ioannis S Vizirianakis and Elsa P Amanatiadou. “Pharmacogenomics and Nanotechnology Toward Advancing Personalized Medicine”. In: Nanomedicine and Nanobiotechnology. Springer, 2011, pp. 115–134.
[47] Meenakshi Verma. “Nanotechnology and its application on drug delivery”. In: Annals of the Romanian Society for Cell Biology 25.1 (2021), pp. 3683–3690.
[48] Gary E Marchant. “Small is beautiful: what can nanotechnology do for personalized medicine?” In: Current Pharmacogenomics and Personalized Medicine 7.4 (2009), pp. 231–237.
Downloads
Published
Issue
Section
License
This work is licensed under a Creative Commons Attribution 4.0 International License.
© The Author(s). Published by Fusion of Multidisciplinary Research, An International Journal (FMR), Netherlands.
This is an open-access article distributed under the Creative Commons Attribution license, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author(s) and source are credited.